Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Raymond Sjaarda (NPI 1811968407)

Field	Value
Entity Type	Individual
Organization	Raymond Sjaarda
Address	6569 N Charles St
City	Baltimore
State	MD
ZIP	21204
Taxonomy	Ophthalmology Physician
NPI Enumerated	January 31, 2006

Payer Source	Total Paid
Medicare	$4.2M
Medicaid	$0

Key Findings

This provider has $4.2M in lifetime Medicare revenue and no Medicaid billing on file, so the practice is effectively single-payer with Medicare as the dominant source of billed revenue. The absence of any Medicaid claims means payer diversification is minimal, which concentrates reimbursement risk on Medicare policy and pricing changes.

Revenue is highly concentrated in intravitreal drug codes: the top three Medicare codes J0178, J2777, and J2778 account for 80.2% of this provider's total Medicare revenue. Individually these are J0178 $1.4M (33.5% of this provider's total Medicare revenue), J2777 $974.4K (23.5% of this provider's total Medicare revenue), and J2778 $964.1K (23.2% of this provider's total Medicare revenue), indicating treatment of retinal vascular disease is the primary revenue driver.

The CPT/HCPCS mix indicates a retina-focused ophthalmology practice that centers on anti-VEGF intravitreal injections and high-volume diagnostic imaging. High-volume injectables (J0178, J2777, J2778) are paired with substantial retinal imaging (92134: 4.5K claims, $139K) and office E/M visits (99214, 99213), plus a smaller but present set of surgical retina codes (67028, 67036, 67042), implying both medical retina services and some surgical capability.

Competitive standing is mixed across codes: J2778 ranks #37 of 1208 providers nationally (97th percentile; notably above typical national volume for this code), signaling unusually high ranibizumab activity compared with peers, while J0178 ranks #535 of 3204 providers nationally (83th percentile; typical, unremarkable volume for this code) and J2777 ranks #243 of 2039 providers nationally (88th percentile; typical, unremarkable volume for this code). Additionally, several non-drug codes are extreme outliers—99214 ranks #510 of 479517 providers nationally (100th percentile; extreme outlier) and 92134 ranks #84 of 26868 providers nationally (100th percentile; extreme outlier)—indicating exceptionally high E/M and retinal imaging volumes versus national peers.

Procedure-level detail shows strong in-office injection activity with parallel diagnostics and lower-volume surgeries. For example, 67028 appears with 2.2K claims and $231K revenue (5.6% of Medicare revenue) and ranks #292 of 4255 providers nationally (93th percentile; notably above typical national volume for this code), while vitrectomy/retinal repair codes such as 67036 (31 claims, $23.3K) and 67042 (28 claims, $27K) contribute smaller shares, consistent with a practice that mainly delivers office-based retina care with some OR procedures.

Billing patterns across drugs suggest unit-based or dosing-differentiated billing drives per-claim payments: J0178 shows 2K claims with $693 avg paid/claim, J2778 shows 5.4K claims with $179 avg paid/claim, and J2777 shows 33.6K claims with $29 avg paid/claim. The large claim count but low per-claim payment for J2777 alongside higher per-claim payments for J0178 and J2778 is consistent with differing dose-unit measures and pricing across anti-VEGF products and materially shapes revenue composition.

Tenure data show the NPI was enumerated 2006-01-31 (~20 years ago), indicating an established practice with long-standing Medicare participation. That longevity, combined with high volumes on key retinal codes, suggests an entrenched clinical focus on retinal disease management.

Concentration in Medicare and in anti-VEGF therapy creates both upside and exposure: the practice captures substantial revenue from high-cost injectables and imaging but has minimal Medicaid activity and limited payer diversification. Changes in Medicare coverage, drug utilization patterns, or pricing could therefore have outsized impact on this provider's revenue profile.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,010	$690	$1.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	33,600	$30	$974.4K
J2778	Injection, ranibizumab, 0.1 mg	5,390	$180	$964.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	2,530	$90	$238K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,200	$110	$231K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	4,490	$30	$139K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,410	$70	$96.9K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	310	$130	$38.9K
67042	In this procedure, the provider removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical cutting tool. He removes the internal limiting membrane of the retina…	30	$970	$27K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	30	$750	$23.3K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Raymond Sjaarda — 5 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	23	100	950	$690	$887.3K
J2777	10	70	8,520	$30	$487.3K
J2778	2	50	650	$180	$207.8K
67028	12	120	700	$100	$101.5K
67042	8	30	20	$1,060	$25.4K
99214	25	10,270	150	$90	$24.1K
67036	4	20	20	$960	$22K
92235	78	90	70	$110	$19.5K
92134	5	490	110	$30	$17.3K
67108	7	20	20	$1,010	$17.2K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Raymond Sjaarda, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Baranano	MD	Ophthalmology Physician	$4.2M	$0
John Thompson	MD	Ophthalmology Physician	$3.9M	$0

Nearby Providers

Other providers in the same ZIP code as Raymond Sjaarda, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Baltimore County Public Schools	MD	Local Education Agency (LEA)	$0	$102.7M
Gilchrist Hospice Care Inc.	MD	Inpatient Hospice	$0	$60.7M
Sheppard Pratt Physicians, P.A.	MD	Psychiatry Physician	$0	$17.3M
Greater Baltimore Medical Center, Inc.	MD	General Practice Physician	$0	$9.4M
Mei Tang	MD	Medical Oncology Physician	$6.9M	$0
Patient First Maryland Medical Group PLLC	MD	Family Medicine Physician	$0	$6.8M
University Of Maryland St. Joseph Medical Group, LLC	MD	General Practice Physician	$0	$6.2M
Sheppard Pratt Physicians PA	MD	Mental Health Counselor	$0	$5.7M
Baltimore County Deparment Of Health	MD	Public Health or Welfare Agency	$0	$5.2M
Dulaney Eye Institute, LLC	MD	Ambulatory Surgical Clinic/Center	$3.1M	$503.5K

Raymond Sjaarda — Billing Profile & Reimbursement Data

Sign up for Raymond Sjaarda — Billing Profile & Reimbursement Data policy alerts

Raymond Sjaarda — Billing Profile & Reimbursement Data

Sign up for Raymond Sjaarda — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References